These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35330486)

  • 21. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.
    Yimer NS; Abiye AA; Hussen SU; Tadesse TA
    Clin Appl Thromb Hemost; 2021; 27():10760296211049786. PubMed ID: 34724849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry.
    Roldán Rabadán I; Esteve-Pastor MA; Anguita-Sánchez M; Muñiz J; Camacho Siles J; Quesada MA; Ruiz Ortiz M; Marín F; Martínez Sellés M; Bertomeu V; Lip GYH; Cequier Fillat A; Badimón L;
    Eur J Clin Invest; 2018 May; 48(5):e12910. PubMed ID: 29424018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry.
    Vitolo M; Proietti M; Malavasi VL; Bonini N; Romiti GF; Imberti JF; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Kalarus Z; Maggioni AP; Lane DA; Lip GYH; Boriani G;
    Eur J Intern Med; 2022 Nov; 105():54-62. PubMed ID: 36028394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention.
    Zulkifly H; Lip GYH; Lane DA
    Int J Clin Pract; 2022; 2022():5951262. PubMed ID: 35685589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry.
    Ding WY; Proietti M; Romiti GF; Vitolo M; Fawzy AM; Boriani G; Marin F; Blomström-Lundqvist C; Potpara TS; Fauchier L; H Lip GY;
    Eur J Intern Med; 2023 Jan; 107():60-65. PubMed ID: 36372692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-anticoagulation by vitamin K antagonists and gender differences.
    Barcellona D; Schirru P; Mameli A; Cornacchini S; Fenu L; Marongiu F
    Int J Cardiol; 2022 Sep; 362():147-151. PubMed ID: 35533748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
    Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
    Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists.
    Lobos-Bejarano JM; Castellanos Rodríguez A; Barrios V; Escobar C; Polo-García J; Del Castillo-Rodríguez JC; Vargas-Ortega D; Lopez-Pineda A; Prieto-Valiente L; Lip GYH;
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28722795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Care for Atrial Fibrillation Using the ABC Pathway in the Prospective APHRS-AF Registry.
    Bucci T; Proietti M; Shantsila A; Romiti GF; Teo WS; Park HW; Shimizu W; Tse HF; Lip GYH; Chao TF;
    JACC Asia; 2023 Aug; 3(4):580-591. PubMed ID: 37614548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated care and outcomes in patients with atrial fibrillation and comorbidities.
    Proietti M; Vitolo M; Lip GYH
    Eur J Clin Invest; 2021 Jun; 51(6):e13498. PubMed ID: 33482011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
    Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
    Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to Atrial Fibrillation Better Care (ABC) Pathway Management of Chinese Community Elderly Patients with Atrial Fibrillation: A Cross-Sectional Study.
    Zhang X; Huang J; Weng F; Wen Y; Wang X; Jiang J; Xue Y; Li K
    Patient Prefer Adherence; 2023; 17():1813-1823. PubMed ID: 37520064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry.
    Gumprecht J; Domek M; Proietti M; Li YG; Asaad N; Rashed W; Alsheikh-Ali A; Zubaid M; Lip GYH
    J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32365582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.
    Bartoli-Abdou JK; Patel JP; Xie R; Dzahini O; Vadher B; Brown A; Roberts LN; Patel RK; Arya R; Auyeung V
    Res Pract Thromb Haemost; 2018 Jul; 2(3):497-507. PubMed ID: 30046754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
    Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
    Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry.
    Wang YF; Jiang C; He L; Du X; Sang CH; Long DY; Tang RB; Dong JZ; Lip GYH; Ma CS
    Front Cardiovasc Med; 2021; 8():762245. PubMed ID: 34869677
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.
    Fitzmaurice DA; Accetta G; Haas S; Kayani G; Lucas Luciardi H; Misselwitz F; Pieper K; Ten Cate H; Turpie AG; Kakkar AK;
    Br J Haematol; 2016 Aug; 174(4):610-23. PubMed ID: 27071942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation.
    Botto GL; Ameri P; De Caterina R
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.